ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

PRAX Praxis Precision Medicines Inc

54.54
0.38 (0.70%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Praxis Precision Medicines Inc PRAX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.38 0.70% 54.54 06:30:00
개장가 저가 고가 종가 전일 종가
55.40 54.345 55.435 54.54 54.16
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
12/04/202421:00GLOBEPraxis Precision Medicines to Present on Ulixacaltamide at..
05/03/202423:08EDGAR2Form S-3 - Registration statement under Securities Act of..
05/03/202421:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/03/202421:13EDGAR2Form 8-K - Current report
05/03/202421:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/02/202410:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202400:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202409:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/02/202406:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
18/01/202406:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202406:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/01/202407:23EDGAR2Form 8-K - Current report
13/01/202407:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/01/202420:01EDGAR2Form 8-K - Current report
11/01/202407:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/01/202406:19GLOBEPraxis Precision Medicines, Inc. Announces Proposed Public..
11/01/202406:10EDGAR2Form 8-K - Current report
10/01/202411:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202411:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202411:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202411:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202307:23EDGAR2Form 8-K - Current report
08/12/202307:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/12/202306:33EDGAR2Form 8-K - Current report
28/11/202321:00GLOBEPraxis Precision Medicines to Showcase Largest Pipeline of..
22/11/202306:00GLOBEPraxis Precision Medicines to Present at the Piper Sandler..
16/11/202322:00GLOBEPraxis Precision Medicines Receives PRIME Designation from..
07/11/202321:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:35EDGAR2Form 8-K - Current report
07/11/202321:00GLOBEPraxis Precision Medicines Provides Corporate Update and..
07/11/202306:24EDGAR2Form 8-K - Current report
02/11/202321:00GLOBEPraxis Precision Medicines to Present at Truist Securities..
16/10/202320:09EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202320:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202320:56EDGAR2Form PRE 14A - Other preliminary proxy statements
03/10/202302:27EDGAR2Form 8-K - Current report
03/10/202302:17GLOBEPraxis Precision Medicines Provides Portfolio Update at 2023..
28/09/202305:15GLOBEPraxis Precision Medicines To Host Hybrid R&D Day on Monday,..
19/09/202323:25APSBiotech Catches Major Premarket Bid
07/09/202321:00GLOBEPraxis Precision Medicines to Present at H.C. Wainwright..
31/08/202321:00GLOBEPraxis Precision Medicines to Present Data from Epilepsy..
09/08/202321:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202321:27EDGAR2Form 8-K - Current report
09/08/202320:00GLOBEPraxis Precision Medicines Provides Corporate Update and..
08/08/202320:00GLOBEPraxis Precision Medicines Announces Positive Data from..
07/08/202320:00GLOBEPraxis Precision Medicines Announces Positive Results of EEG..

최근 히스토리

Delayed Upgrade Clock